Bürge Kabukçu Başay
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Bürge Kabukçu Başay has a total of 231 co-authors. Here are the top co-authors by number of shared publications:
- Ömer Başay
Pamukkale University
17 shared publications - Ahmet Büber
Pamukkale University
8 shared publications - Eyüp Sabri Ercan
Department of Child and Adolescent Psychiatry, Ege University, İzmir, Turkey
6 shared publications - Merve Aktaş Terzioğlu
Pamukkale University
5 shared publications - Ali Evren Tufan
Department of Child and Adolescent Psychiatry, Bolu Abant İzzet Baysal University Medical Faculty, Bolu, Turkey
4 shared publications - Fethiye Kılıçaslan
Department of Child and Adolescent Psychiatry, Harran University, Faculty of Medicine, Sanliurfa, Turkey
3 shared publications
Latest Publications
- Open Access
- 27 October 2026
- Published by Springer Nature in BMC Women's Health
Psychological and cognitive symptom correlates of dysmenorrhoea severity in adolescents: a cross-sectional study of cognitive disengagement syndrome
Background: Dysmenorrhoea may be associated with psychological and attention-related difficulties in adolescence. Cognitive disengagement syndrome (CDS), characterised by daydreaming and mental fogginess, overlaps with internalising symptoms, but its relationship with dysmenorrhoea is unclear. We examined whether CDS was related to menstrual pain beyond psychological distress. Methods: This cross-sectional study included 205 girls aged 12–17 years from a child and adolescent psychiatry clinic. Menstrual pain intensity was measured on a 0–10 visual analogue scale (VAS). Adolescents and parents completed measures of CDS, attention-deficit and hyperactivity/impulsivity symptoms, and executive functioning; adolescents completed the Brief Symptom Inventory (BSI). One item assessed everyday-life impact. Analyses used Spearman correlations, non-parametric comparisons, hierarchical linear regression, and binary logistic regression; bivariate p -values were adjusted for the false discovery rate ( q ). Results: Menstrual pain intensity showed small correlations with adolescent-reported CDS (ρ = 0.21), attention-deficit (ρ = 0.17), hyperactivity/impulsivity (ρ = 0.18), and all five BSI subscales (ρ = 0.16–0.26; all q < 0.05), but not with executive functioning ( n = 167) or any parent-reported measure. After adjustment for age and body mass index, CDS was associated with pain intensity ( B = 0.022, 95% CI 0.005–0.039); the association was not evident after adding psychological distress ( B = − 0.004, 95% CI − 0.030 to 0.023). Psychological distress was associated with higher pain intensity ( B = 0.014, 95% CI 0.003–0.025), and the model explained 8.9% of the variance. 112 adolescents (54.6%) reported an appreciable adverse impact on everyday life. In the fully adjusted complete-case model ( n = 196; 106 events), greater pain intensity (OR 1.82 per VAS point, 95% CI 1.51–2.25) and lower body mass index (OR 0.83 per kg/m² increase, 95% CI 0.75–0.91) were associated with this outcome; CDS, psychological distress, and sleep problems were not statistically significant. Conclusions: In this psychiatric outpatient sample, menstrual pain co-occurred with small elevations in adolescent-reported CDS, attention-related symptoms, and psychological distress; no parent-reported associations were found. CDS showed no additional association with pain after adjustment for psychological distress. These cross-sectional findings support asking adolescents directly about menstrual pain, but cannot establish causality or temporal direction.
- 27 October 2026
- Published by Springer Nature in BMC Women's Health
Open AccessPsychological and cognitive symptom correlates of dysmenorrhoea severity in adolescents: a cross-sectional study of cognitive disengagement syndrome
Background: Dysmenorrhoea may be associated with psychological and attention-related difficulties in adolescence. Cognitive disengagement syndrome (CDS), characterised by daydreaming and mental fogginess, overlaps with internalising symptoms, but its relationship with dysmenorrhoea is unclear. We examined whether CDS was related to menstrual pain beyond psychological distress. Methods: This cross-sectional study included 205 girls aged 12–17 years from a child and adolescent psychiatry clinic. Menstrual pain intensity was measured on a 0–10 visual analogue scale (VAS). Adolescents and parents completed measures of CDS, attention-deficit and hyperactivity/impulsivity symptoms, and executive functioning; adolescents completed the Brief Symptom Inventory (BSI). One item assessed everyday-life impact. Analyses used Spearman correlations, non-parametric comparisons, hierarchical linear regression, and binary logistic regression; bivariate p -values were adjusted for the false discovery rate ( q ). Results: Menstrual pain intensity showed small correlations with adolescent-reported CDS (ρ = 0.21), attention-deficit (ρ = 0.17), hyperactivity/impulsivity (ρ = 0.18), and all five BSI subscales (ρ = 0.16–0.26; all q < 0.05), but not with executive functioning ( n = 167) or any parent-reported measure. After adjustment for age and body mass index, CDS was associated with pain intensity ( B = 0.022, 95% CI 0.005–0.039); the association was not evident after adding psychological distress ( B = − 0.004, 95% CI − 0.030 to 0.023). Psychological distress was associated with higher pain intensity ( B = 0.014, 95% CI 0.003–0.025), and the model explained 8.9% of the variance. 112 adolescents (54.6%) reported an appreciable adverse impact on everyday life. In the fully adjusted complete-case model ( n = 196; 106 events), greater pain intensity (OR 1.82 per VAS point, 95% CI 1.51–2.25) and lower body mass index (OR 0.83 per kg/m² increase, 95% CI 0.75–0.91) were associated with this outcome; CDS, psychological distress, and sleep problems were not statistically significant. Conclusions: In this psychiatric outpatient sample, menstrual pain co-occurred with small elevations in adolescent-reported CDS, attention-related symptoms, and psychological distress; no parent-reported associations were found. CDS showed no additional association with pain after adjustment for psychological distress. These cross-sectional findings support asking adolescents directly about menstrual pain, but cannot establish causality or temporal direction.
- Open Access
- 17 October 2026
- Published by SAGE Publications in Journal of Attention Disorders
Extended-Release Guanfacine Hydrochloride is Safe and Effective as Mono- and Adjunctive Therapy in Children and Adolescents with ADHD: A Naturalistic, Multi-Center, Patient-Reported Outcome Measures–Based Study
Aims: Attention-deficit hyperactivity disorder (ADHD) is characterized by impairing and age-inappropriate inattention, hyperactivity, and impulsivity. Extended-release guanfacine hydrochloride (GXR) is a selective α2A-adrenergic agonist approved as mono- and adjunctive therapy to psychostimulant medications for ADHD. This multicenter retrospective study aimed to assess patients with ADHD initiating treatment with GXR as mono- and adjunctive therapy in a non-Western, real-world clinical setting. Methods: The study was designed as a naturalistic, Patient-Reported Outcome Measures (PROMs)-based, clinic-based, multi-center study; thirty-two child and adolescent psychiatry clinics from 26 cities located in seven geographical regions of Türkiye were included. Clinicians evaluated ADHD symptom severity at baseline and at the end of the 6th month with Clinical Global Impressions (CGI)-Severity, Improvement, and Adverse Effect scales while parents evaluated symptoms with the DSM-IV-Based Screening Scale for Disruptive Behavior Disorders. Adverse effects after GXR treatment were determined from patient records. Dose equivalents for stimulants, antidepressants, antipsychotics, and mood stabilizers used concurrently with GXR were calculated. Univariate and bivariate analyses along with linear mixed models were used to model change. Logistic regression was used to evaluate predictors of treatment response in sensitivity analysis. Results: Five hundred and sixty-seven patients ( n = 437, 77.1% male) with a mean age of 11.2 ( SD = 2.8) years were enrolled. Comorbid diagnoses were common (82.4%) along with combination therapy (85.0%). GXR at a median dose of 2.0 to 3.0 mg/day was associated with improvement and the rate of adverse effects was low. GXR showed differential symptom-domain effects, with greater improvement in hyperactive-impulsive (HI) compared to inattentive (IA) symptoms. Children with comorbid autism spectrum disorder (ASD; n = 175, 30.0% of the sample) showed notable clinical improvement. Response was modified by baseline symptom severity. Conclusion: GXR may be a viable treatment option for children and adolescents with ADHD and various comorbidities among Turkish youth in real-world clinical populations, with baseline symptom severity as a potential modifier of response. The differential response favoring HI symptoms and notable effectiveness in comorbid ASD represent clinically important findings of this naturalistic, PROM-based study.
- 17 October 2026
- Published by SAGE Publications in Journal of Attention Disorders
Open AccessExtended-Release Guanfacine Hydrochloride is Safe and Effective as Mono- and Adjunctive Therapy in Children and Adolescents with ADHD: A Naturalistic, Multi-Center, Patient-Reported Outcome Measures–Based Study
Aims: Attention-deficit hyperactivity disorder (ADHD) is characterized by impairing and age-inappropriate inattention, hyperactivity, and impulsivity. Extended-release guanfacine hydrochloride (GXR) is a selective α2A-adrenergic agonist approved as mono- and adjunctive therapy to psychostimulant medications for ADHD. This multicenter retrospective study aimed to assess patients with ADHD initiating treatment with GXR as mono- and adjunctive therapy in a non-Western, real-world clinical setting. Methods: The study was designed as a naturalistic, Patient-Reported Outcome Measures (PROMs)-based, clinic-based, multi-center study; thirty-two child and adolescent psychiatry clinics from 26 cities located in seven geographical regions of Türkiye were included. Clinicians evaluated ADHD symptom severity at baseline and at the end of the 6th month with Clinical Global Impressions (CGI)-Severity, Improvement, and Adverse Effect scales while parents evaluated symptoms with the DSM-IV-Based Screening Scale for Disruptive Behavior Disorders. Adverse effects after GXR treatment were determined from patient records. Dose equivalents for stimulants, antidepressants, antipsychotics, and mood stabilizers used concurrently with GXR were calculated. Univariate and bivariate analyses along with linear mixed models were used to model change. Logistic regression was used to evaluate predictors of treatment response in sensitivity analysis. Results: Five hundred and sixty-seven patients ( n = 437, 77.1% male) with a mean age of 11.2 ( SD = 2.8) years were enrolled. Comorbid diagnoses were common (82.4%) along with combination therapy (85.0%). GXR at a median dose of 2.0 to 3.0 mg/day was associated with improvement and the rate of adverse effects was low. GXR showed differential symptom-domain effects, with greater improvement in hyperactive-impulsive (HI) compared to inattentive (IA) symptoms. Children with comorbid autism spectrum disorder (ASD; n = 175, 30.0% of the sample) showed notable clinical improvement. Response was modified by baseline symptom severity. Conclusion: GXR may be a viable treatment option for children and adolescents with ADHD and various comorbidities among Turkish youth in real-world clinical populations, with baseline symptom severity as a potential modifier of response. The differential response favoring HI symptoms and notable effectiveness in comorbid ASD represent clinically important findings of this naturalistic, PROM-based study.
- Open Access
- 10 October 2026
- Published by Pamukkale University in Pamukkale Medical Journal
- Vol. 19 (4) , 697-706
Perspectives of physicians' in child and adolescent psychiatry in Türkiye on the use of telepsychiatry in training and clinical practice
Purpose: This study aimed to evaluate the awareness, knowledge, and attitudes of physicians working in the field of Child and Adolescent Psychiatry in Türkiye toward telepsychiatry.Materials and methods: This cross-sectional descriptive study was conducted using an online questionnaire. Of the 121 physicians reached across Türkiye, 105 completed the survey. Data were collected using a sociodemographic information form and a 27-item telepsychiatry attitude form developed by the researchers. The overall telepsychiatry attitude score was calculated from relevant items between questions 8 and 38 and scored on a 0-1 scale. Multiple linear regression analysis was conducted to determine the predictors of the general attitude score toward telepsychiatry.Results: The mean age of participants was 32.86±6.07 years, and 78.1% were female. The mean attitude score was 0.74±0.13; 37.1% of participants had a high, 52.4% a moderate, and 10.5% a low level of positive attitude. Using it in clinical practice (p=0.001), perceiving that it improves patient compliance (p
- 10 October 2026
- Published by Pamukkale University in Pamukkale Medical Journal
- Vol. 19 (4) , 697-706
Open AccessPerspectives of physicians' in child and adolescent psychiatry in Türkiye on the use of telepsychiatry in training and clinical practice
Purpose: This study aimed to evaluate the awareness, knowledge, and attitudes of physicians working in the field of Child and Adolescent Psychiatry in Türkiye toward telepsychiatry.Materials and methods: This cross-sectional descriptive study was conducted using an online questionnaire. Of the 121 physicians reached across Türkiye, 105 completed the survey. Data were collected using a sociodemographic information form and a 27-item telepsychiatry attitude form developed by the researchers. The overall telepsychiatry attitude score was calculated from relevant items between questions 8 and 38 and scored on a 0-1 scale. Multiple linear regression analysis was conducted to determine the predictors of the general attitude score toward telepsychiatry.Results: The mean age of participants was 32.86±6.07 years, and 78.1% were female. The mean attitude score was 0.74±0.13; 37.1% of participants had a high, 52.4% a moderate, and 10.5% a low level of positive attitude. Using it in clinical practice (p=0.001), perceiving that it improves patient compliance (p
- 5 October 2026
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 204, 49-56
Altered toll-like receptor expression in autism spectrum disorder: Evidence from mRNA and serum protein analyses
- 5 October 2026
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 204, 49-56
Altered toll-like receptor expression in autism spectrum disorder: Evidence from mRNA and serum protein analyses
- Open Access
- 26 August 2026
- Published by Springer Nature in Middle East Current Psychiatry
- Vol. 33 (1) , 62
Psychometric properties of the Irritability and Dysregulation of Emotion Scale (TIDES-13) and Emotional Outburst Inventory (EMO-I) in a transdiagnostic sample of Turkish youth
Objective: Irritability is a transdiagnostic phenomenon within the irritability-anger-aggression spectrum, but available measures often fail to capture its multifaceted nature. This study evaluated the psychometric properties and clinical utility of two new measures: the Emotional Outburst Inventory (EMO-I), assessing phasic irritability phenomenology, and the Irritability and Dysregulation of Emotion Scale (TIDES-13), designed as a multidimensional measure. Method: In a clinical sample of 113 Turkish children and adolescents (54% males, the age mean of 11.80 (3.89) years), one parent completed the EMO-I, TIDES-13, Affective Reactivity Index (ARI), and several measures of psychopathology (T-DSM-IV-S, Revised Child Anxiety and Depression Scale [RCADS], and Strengths and Difficulties Questionnaire [SDQ]). Self-reports (n = 87) were obtained for the TIDES-13, ARI, RCADS, and SDQ. Exploratory factor analysis, internal consistency, intraclass correlation coefficient (ICC), convergent/incremental validity, and group comparisons were conducted. Results: Factor analysis supported a unidimensional structure for the parent-report TIDES-13 and a two-factor solution for the self-report version. Both TIDES-13 versions showed excellent internal consistency (α = 0.97 for the parent and 0.93 for the self-report), with ICC = 0.45 for single and 0.62 average measures. The TIDES-13 demonstrated robust correlations with externalizing and internalizing symptoms ( r = 0.23–0.63) and superior incremental validity over ARI for predicting attention deficit hyperactivity disorder (ADHD) and conduct symptoms. The EMO-I dimensions (severity, frequency, duration, baseline irritability) were moderately intercorrelated and showed modest associations with psychopathology. The TIDES-13 accounted for significant unique variance in psychopathology beyond EMO-I, whereas the EMO-I showed limited incremental validity beyond ARI and TIDES-13. No significant diagnostic group differences were found on either measure. Conclusions: The TIDES-13 is a psychometrically robust, transdiagnostic measure of irritability suitable for Turkish clinical settings. The EMO-I provides detailed phenomenology of emotional outbursts. Findings support the complementary use of TIDES-13 for assessing trait irritability and EMO-I for detailing episodic outbursts. Future studies using larger and longitudinal samples are warranted to further establish the developmental and clinical implications of these measures, especially considering the limitations of this study.
- 26 August 2026
- Published by Springer Nature in Middle East Current Psychiatry
- Vol. 33 (1) , 62
Open AccessPsychometric properties of the Irritability and Dysregulation of Emotion Scale (TIDES-13) and Emotional Outburst Inventory (EMO-I) in a transdiagnostic sample of Turkish youth
Objective: Irritability is a transdiagnostic phenomenon within the irritability-anger-aggression spectrum, but available measures often fail to capture its multifaceted nature. This study evaluated the psychometric properties and clinical utility of two new measures: the Emotional Outburst Inventory (EMO-I), assessing phasic irritability phenomenology, and the Irritability and Dysregulation of Emotion Scale (TIDES-13), designed as a multidimensional measure. Method: In a clinical sample of 113 Turkish children and adolescents (54% males, the age mean of 11.80 (3.89) years), one parent completed the EMO-I, TIDES-13, Affective Reactivity Index (ARI), and several measures of psychopathology (T-DSM-IV-S, Revised Child Anxiety and Depression Scale [RCADS], and Strengths and Difficulties Questionnaire [SDQ]). Self-reports (n = 87) were obtained for the TIDES-13, ARI, RCADS, and SDQ. Exploratory factor analysis, internal consistency, intraclass correlation coefficient (ICC), convergent/incremental validity, and group comparisons were conducted. Results: Factor analysis supported a unidimensional structure for the parent-report TIDES-13 and a two-factor solution for the self-report version. Both TIDES-13 versions showed excellent internal consistency (α = 0.97 for the parent and 0.93 for the self-report), with ICC = 0.45 for single and 0.62 average measures. The TIDES-13 demonstrated robust correlations with externalizing and internalizing symptoms ( r = 0.23–0.63) and superior incremental validity over ARI for predicting attention deficit hyperactivity disorder (ADHD) and conduct symptoms. The EMO-I dimensions (severity, frequency, duration, baseline irritability) were moderately intercorrelated and showed modest associations with psychopathology. The TIDES-13 accounted for significant unique variance in psychopathology beyond EMO-I, whereas the EMO-I showed limited incremental validity beyond ARI and TIDES-13. No significant diagnostic group differences were found on either measure. Conclusions: The TIDES-13 is a psychometrically robust, transdiagnostic measure of irritability suitable for Turkish clinical settings. The EMO-I provides detailed phenomenology of emotional outbursts. Findings support the complementary use of TIDES-13 for assessing trait irritability and EMO-I for detailing episodic outbursts. Future studies using larger and longitudinal samples are warranted to further establish the developmental and clinical implications of these measures, especially considering the limitations of this study.
- Open Access
- 30 July 2026
- Published by Springer Nature in BMC Psychiatry
- Vol. 26 (1)
Plasma chromogranin a levels and their role in the etiology of anxiety disorders in children and adolescents
- 30 July 2026
- Published by Springer Nature in BMC Psychiatry
- Vol. 26 (1)
Open AccessPlasma chromogranin a levels and their role in the etiology of anxiety disorders in children and adolescents
- Open Access
- 10 July 2026
- Published by Pamukkale University in Pamukkale Medical Journal
- Vol. 19 (3) , 7-23
Unraveling clinical profiles and predictive factors of length of stay in hospitalized children and adolescents in mental health services
Purpose: The aim of this study is to investigate the clinical characteristics of pediatric and adolescent patients admitted to the Child and Adolescent Psychiatry Inpatient Service, to retrospectively evaluate their length of stay, recurrent admissions, and treatment processes, and to identify factors predicting the duration of hospitalization.Materials and methods: In this study, data from 512 children and adolescents aged 5-18 years, admitted to the Child and Adolescent Psychiatry Inpatient Service between 01.01.2016 and 01.09.2024, were retrospectively reviewed and collected from hospital records and patient files.Results: It was observed that 66% of the hospitalized patients were female, with depressive disorder being the most common diagnosis. The most frequently prescribed medication was antipsychotics, followed by antidepressants, and approximately one-third of the patients were using multiple antipsychotics. In patients who received Electroconvulsive Therapy (ECT), the use of mood stabilizers, anxiolytics, and combinations of antipsychotics and mood stabilizers was significantly higher. Similarly, in patients who received Transcranial Magnetic Stimulation (TMS) treatment, the use of SNRIs and multiple antipsychotics was higher. Factors predicting longer length of stay included the use of antipsychotics, mood stabilizers, multiple medications of the same class (multiple antipsychotics and antidepressants), and the administration of advanced treatments such as ECT and TMS.Conclusion: In cases where children and adolescents are prescribed antipsychotics, mood stabilizers, and particularly multiple antipsychotics and antidepressants, the timely implementation of treatment protocols such as ECT and TMS may be effective in reducing the length of hospitalization and mitigating prolonged inpatient stays.
- 10 July 2026
- Published by Pamukkale University in Pamukkale Medical Journal
- Vol. 19 (3) , 7-23
Open AccessUnraveling clinical profiles and predictive factors of length of stay in hospitalized children and adolescents in mental health services
Purpose: The aim of this study is to investigate the clinical characteristics of pediatric and adolescent patients admitted to the Child and Adolescent Psychiatry Inpatient Service, to retrospectively evaluate their length of stay, recurrent admissions, and treatment processes, and to identify factors predicting the duration of hospitalization.Materials and methods: In this study, data from 512 children and adolescents aged 5-18 years, admitted to the Child and Adolescent Psychiatry Inpatient Service between 01.01.2016 and 01.09.2024, were retrospectively reviewed and collected from hospital records and patient files.Results: It was observed that 66% of the hospitalized patients were female, with depressive disorder being the most common diagnosis. The most frequently prescribed medication was antipsychotics, followed by antidepressants, and approximately one-third of the patients were using multiple antipsychotics. In patients who received Electroconvulsive Therapy (ECT), the use of mood stabilizers, anxiolytics, and combinations of antipsychotics and mood stabilizers was significantly higher. Similarly, in patients who received Transcranial Magnetic Stimulation (TMS) treatment, the use of SNRIs and multiple antipsychotics was higher. Factors predicting longer length of stay included the use of antipsychotics, mood stabilizers, multiple medications of the same class (multiple antipsychotics and antidepressants), and the administration of advanced treatments such as ECT and TMS.Conclusion: In cases where children and adolescents are prescribed antipsychotics, mood stabilizers, and particularly multiple antipsychotics and antidepressants, the timely implementation of treatment protocols such as ECT and TMS may be effective in reducing the length of hospitalization and mitigating prolonged inpatient stays.
- 5 June 2026
- Published by Academician Publishing
- p. 223-236
DEHB ve Obsesif Kompulsif Bozukluk Komorbiditesi
- 5 June 2026
- Published by Academician Publishing
- p. 223-236
DEHB ve Obsesif Kompulsif Bozukluk Komorbiditesi
- 19 May 2026
- Published by Taylor & Francis in Developmental Neuropsychology
- Vol. 51 (3-4) , 215-229
ADHD Prevalence in Turkish Preschoolers: Comorbidity and Associated Factors
Attention-deficit/hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders, characterized by inattention, hyperactivity, and impulsivity (2013). ADHD disrupts children’s...
- 19 May 2026
- Published by Taylor & Francis in Developmental Neuropsychology
- Vol. 51 (3-4) , 215-229
ADHD Prevalence in Turkish Preschoolers: Comorbidity and Associated Factors
Attention-deficit/hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders, characterized by inattention, hyperactivity, and impulsivity (2013). ADHD disrupts children’s...